The effect of prophylactic carvedilol on subclinical left ventricular dysfunction after 1 cycle FAC chemotherapy in breast cancer patients

BACKGROUND: Despite its efficacy, FAC regimen may cause fatal cardiotoxicity. Carvedilol may also exert additional antioxidant effects. This study aimed to assess the effect of carvedilol in preventing decline of left ventricular function in breast cancer patients receiving FAC regimen chemotherapy....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Cardiol Heart Vasc
Hlavní autoři: Wibawa Martha, Januar, Soedarsono, Dery A., Iqbal, Mohammad, Astuti, Astri, Martanto, Erwan, Rizki Akbar, Mohammad, Sumantra, I. Gede
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7339049/
https://ncbi.nlm.nih.gov/pubmed/32671185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100575
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky